Lu Dongmei, Abulimiti Ayiniger, Wu Ting, Abudureyim Ailigen, Li Nanfang
The Center of Hypertension of the People's Hospital of Xinjiang Uygur Autonomous Region, The Center of Diagnosis, Treatment and Research of Hypertension in Xinjiang Hypertension Institute of Xinjiang, Urumqi, China.
The Department of Pulmonary and Critical Care Medicine of the People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, China.
Sleep Breath. 2018 Mar;22(1):99-107. doi: 10.1007/s11325-017-1536-z. Epub 2017 Jul 13.
Pulmonary surfactant (PS) plays roles in promoting the removal of the liquid, host defense, and immune regulation in the tracheal, bronchial, and alveoli epithelium. PS protein expression level can be regulated by oxygen levels and related free radicals. Obstructive sleep apnea (OSA) is featured with oxygen free radical production for damaging epithelial tissues and thus may affect PS production. The study was to explore the relationship between PS protein and OSA severity.
We collected serum and bronchoalveolar lavage fluid (BALF) samples from 35 OSA patients and 22 healthy subjects. PS-associated proteins and inflammatory factors, including surfactant proteins, HIF-1α, NF-κB, and IL-6, were analyzed. Regression analysis was performed to reveal the relationship between biochemical factors and clinical indexes recorded during PSG monitor.
Lower BALF and surfactant protein (except surfactant protein C or SPC) levels occurred in OSA patients (all p < 0.05 compared to control group). A strongly negative correlation was found between surfactant protein with apnea-hypopnea index (AHI) and other sleeping indexes including ODI and ODI. Similar patterns were found in serum samples, which were strongly correlated with BALF counterparts. Surfactant proteins were further found to have negative regression with inflammatory factors such as HIF-1α, NF-κB, and IL-6.
This study established the relationship between PS-related protein with severity of OSA, plus their relationship with inflammatory factors. Our results provided possibly novel markers in general circulation for disease evaluation of OSA.
肺表面活性物质(PS)在促进气管、支气管和肺泡上皮细胞中液体清除、宿主防御及免疫调节方面发挥作用。PS蛋白表达水平可受氧水平及相关自由基调节。阻塞性睡眠呼吸暂停(OSA)的特征是产生氧自由基,损伤上皮组织,进而可能影响PS的产生。本研究旨在探讨PS蛋白与OSA严重程度之间的关系。
我们收集了35例OSA患者和22名健康受试者的血清及支气管肺泡灌洗液(BALF)样本。分析了与PS相关的蛋白及炎症因子,包括表面活性蛋白、缺氧诱导因子-1α(HIF-1α)、核因子κB(NF-κB)和白细胞介素-6(IL-6)。进行回归分析以揭示生化因素与PSG监测期间记录的临床指标之间的关系。
OSA患者的BALF及表面活性蛋白(表面活性蛋白C或SPC除外)水平较低(与对照组相比,所有p<0.05)。表面活性蛋白与呼吸暂停低通气指数(AHI)及其他睡眠指标(包括氧减指数(ODI))之间存在强烈的负相关。血清样本中也发现了类似模式,与BALF样本密切相关。进一步发现表面活性蛋白与HIF-1α、NF-κB和IL-6等炎症因子呈负相关。
本研究确立了PS相关蛋白与OSA严重程度之间的关系,以及它们与炎症因子的关系。我们的结果为OSA疾病评估提供了可能的新的循环标志物。